Consolidated Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 216	$ 111
Total current assets	216	111
Other noncurrent assets	145,000
Total assets	145,216	111
Current liabilities:
Accounts payable	165,466	165,466
Accrued liabilities	990,078	1,554,862
Convertible notes payable, current	1,407,701	1,559,803
Derivative liabilities	2,747,418	2,298,820
Promissory notes payable	12,500
Related party payables	6,055	4,505
Total current liabilities	5,329,218	5,583,456
Total liabilities	5,329,218	5,583,456
Commitments and contingencies
Stockholders' Deficit:
Preferred stock - Series A, $0.00001 par value. 69,999,990 shares authorized; 10,000,000 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	100	100
Preferred stock - Series D, $0.00001 par value. 1 share authorized; zero 0 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively
Preferred stock - Series E, $0.00001 par value. 50 shares authorized; 50 and 20 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively
Common stock, $0.001 par value. 1,000,000,000 shares authorized; 123,197,371 and 101,929,993 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	123,197	101,930
Additional paid-in capital	10,354,315	8,984,752
Accumulated deficit	(15,661,614)	(14,670,127)
Total stockholders' deficit	(5,184,002)	(5,583,345)
Total liabilities and stockholders' deficit	$ 145,216	$ 111